Explain this page
Arphra AIPlain-English read on Boston Scientific Corporation’s valuationTransactions
19
0 buys · 19 sells
Bought
$0
Open market
Sold
$53.47M
Open market
Net flow
−$53.47M
Buys − sells
Transactions
| Insider | Role | Action | Shares | Price | Value | Trade date | Filing |
|---|---|---|---|---|---|---|---|
| Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 159,701 | $93.49 | $14.93M | Feb 02, 2026 | Feb 03, 2026 |
| Mahoney Michael F | director, officer: Chairman, President & CEO | Sell | 1,200 | $94.06 | $112.87K | Feb 02, 2026 | Feb 03, 2026 |
| Butcher Arthur C | officer: EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $101.55 | $1.76M | Dec 01, 2025 | Dec 02, 2025 |
| Zane Ellen M | director | Sell | 12,891 | $98.28 | $1.27M | Nov 06, 2025 | Nov 06, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 16,928 | $99.76 | $1.69M | Nov 03, 2025 | Nov 04, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 29,472 | $99.14 | $2.92M | Nov 03, 2025 | Nov 04, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 3,600 | $100.75 | $362.69K | Nov 03, 2025 | Nov 04, 2025 |
| Zane Ellen M | director | Sell | 2,901 | $102.24 | $296.6K | Oct 28, 2025 | Oct 28, 2025 |
| Zane Ellen M | director | Sell | 9,990 | $101.13 | $1.01M | Oct 27, 2025 | Oct 28, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 8,245 | $98.91 | $815.48K | Oct 01, 2025 | Oct 01, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 41,755 | $98.38 | $4.11M | Oct 01, 2025 | Oct 01, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 28,170 | $105.85 | $2.98M | Sep 02, 2025 | Sep 03, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 21,830 | $104.89 | $2.29M | Sep 02, 2025 | Sep 03, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 50,000 | $104.63 | $5.23M | Aug 01, 2025 | Aug 04, 2025 |
| Butcher Arthur C | officer: EVP& Grp Pres, MedSurg & APAC | Sell | 17,313 | $104.63 | $1.81M | Aug 01, 2025 | Aug 04, 2025 |
| FUJIMORI YOSHIAKI | director | Sell | 2,901 | $106.99 | $310.38K | Jul 29, 2025 | Jul 30, 2025 |
| LUDWIG EDWARD J | director | Sell | 4,000 | $106.03 | $424.12K | Jul 25, 2025 | Jul 28, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 50,000 | $106.97 | $5.35M | Jul 01, 2025 | Jul 02, 2025 |
| Fitzgerald Joseph Michael | officer: EVP & Group Pres, Cardiology | Sell | 56,372 | $102.88 | $5.8M | Jun 04, 2025 | Jun 04, 2025 |
By insider
- Fitzgerald Joseph Michael−$31.55Mofficer: EVP & Group Pres, Cardiology0B · 10S
- Mahoney Michael F−$15.04Mdirector, officer: Chairman, President & CEO0B · 2S
- Butcher Arthur C−$3.57Mofficer: EVP& Grp Pres, MedSurg & APAC0B · 2S
- Zane Ellen M−$2.57Mdirector0B · 3S
- LUDWIG EDWARD J−$424.12Kdirector0B · 1S
- FUJIMORI YOSHIAKI−$310.38Kdirector0B · 1S
Beneficial ownership filings
Schedule 13D / 13G — investors holding more than 5% of BSX-US.
DB · acquisition_ownership10
| Filed | Reporting person | Form | Type | Aggregate owned | % Class | Sole voting | Shared voting | Citizenship | |
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Boston Scientific Corporation | — | CO | — | +8.00% | 543.97K | 0 | — | SEC → |
| Feb 09, 2022 | FMR LLC | — | HC | — | +7.02% | 12.18M | 0 | Delaware | SEC → |
| Feb 09, 2022 | Abigail P. Johnson | — | IN | — | +7.02% | 0 | 0 | United States of America | SEC → |
| Feb 09, 2022 | The Vanguard Group - 23-1945930 | — | IA | — | +7.83% | 0 | 2.24M | Pennsylvania | SEC → |
| Feb 08, 2022 | (1) BlackRock, Inc. | — | HC | — | +9.00% | 113.56M | 0 | Delaware | SEC → |
| Feb 04, 2022 | Wellington Group Holdings LLP | — | HC | — | +5.22% | 0 | 68.68M | — | SEC → |
| Feb 04, 2022 | Wellington Management Group LLP | — | HC | — | +5.22% | 0 | 68.68M | — | SEC → |
| Feb 04, 2022 | Wellington Investment Advisors Holdings LLP | — | HC | — | +5.22% | 0 | 68.68M | — | SEC → |
| Feb 03, 2022 | Boston Scientific Corporation | — | CO | — | +36.00% | 0 | 0 | Delaware | SEC → |
| Feb 02, 2022 | 04-2747644 | — | IA | — | +6.10% | 78.27M | 0 | Delaware | SEC → |
Top 10 holders · 8 quarters
13F position evolutionNo 13F history in
institutional_holders for BSX-US.